Who is sponsoring NCT05862350?

NCT05862350 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT05862350?

Interventions in NCT05862350: aromatherapy inhalation with lavender essential oil, aromatherapy inhalation with coconut essential oil..

What condition does NCT05862350 study?

NCT05862350 studies Chronic Heart Failure.

Is NCT05862350 still recruiting?

NCT05862350 is currently status unknown. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT05862350

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Lavender Essential Oil in Patients With Chronic Heart Failure

Status unknown NA Last updated 17 May 2023

What this trial tests

NA trial testing aromatherapy inhalation with lavender essential oil in Chronic Heart Failure in 60 participants. Status unknown.

Timeline

10 May 2023

Primary endpoint
30 July 2023

30 October 2023

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	10 May 2023
Primary completion	30 July 2023
Estimated completion	30 October 2023

Drugs / interventions tested

aromatherapy inhalation with lavender essential oil
aromatherapy inhalation with coconut essential oil.

Conditions studied

Chronic Heart Failure — all drugs for Chronic Heart Failure →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Adults 18 to 80, any sex, with Chronic Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the trial is to study the effects of lavender essential oil on sleep quality, anxiety, and fatigue in patients with chronic heart failure. The main questions it may answer are 1. effects of lavender essential oil on sleep quality 2. effects of lavender essential oil on anxiety 3. effects of lavender essential oil on fatigue Patients will be randomly divided into experimental and control groups, the control group will inhale essential coconut oil, and the experimental group will inhale lavender essential oil for four weeks. At baseline, on the 7th day, and 28th day, the sleep quality, anxiety, and fatigue will be evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of lavender essential oil inhalation on sleep quality and fatigue in patients with chronic heart failure: a randomised controlled trial.
Hu J, Chong MS, Jia Y, Wu Y, et al · · 2026 · cited 1× · PMID 41499426 · DOI 10.1093/eurjcn/zvag006

Verify or expand the search:

Other recruiting trials for Chronic Heart Failure

Currently open trials in the same condition.

NCT07265349 — A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure · Phase 1, PHASE2 · recruiting
NCT07379840 — A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South K · recruiting
NCT07325942 — Effectiveness of Low -Versus High -Volume High -Intensity Interval Training in Patients With Chronic Heart Failure · NA · recruiting
NCT07434193 — Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergo · NA · recruiting
NCT07405944 — Vericiguat and Reverse Remodeling Indices in Heart Failure · Phase 4 · recruiting

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05862350 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05862350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing